MacroGenics | Kortsiktig Gjeld



Current Liabilities Endring Dato
AbbVie USD 38.75B 4.31B 2024-12
Amgen USD 23.1B 2.79B 2024-12
AstraZeneca USD 27.87B 1.94B 2024-12
Biogen USD 5.53B 103.8M 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Daiichi Sankyo JPY 712.36B 68.42B 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Genmab DKK 5.31B 723M 2024-12
Geron USD 88.3M 49.64M 2024-12
Gilead Sciences USD 12B 279M 2024-12
J&J USD 50.32B 1.44B 2024-12
MacroGenics USD 59.31M 1.4M 2024-09
Merck USD 28.42B 1.17B 2024-12
Pfizer USD 43B 216M 2024-12
Regeneron Pharmaceuticals USD 5.7B 2.04B 2024-12
Roche Holding CHF 27.02B 424M 2024-12
Xencor USD 87.43M 4.54M 2024-12



MacroGenics Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.